Radwa Aly, President of the Board of Directors at INSciTS-International Network for the Science of Team Science, Chief and Executive Director, Clinical Research Administration and Operations of The GW Medical Faculty Associates, shared a post by Hadi Danawi, Global President of MENASA Group, on LinkedIn, adding:
“I’m honored and excited to join the MENASA Group as a Country Leader.
This role is deeply meaningful to me, both personally and professionally, and I’m grateful for the opportunity to contribute to an organization so clearly committed to advancing equity in clinical research.
I look forward to supporting MENASA’s mission to advocate for equitable participation and representation of MENASA communities in clinical research, helping to establish vital drug safety profiles and improve health outcomes through education, collaboration, and innovation. Ensuring that our communities are meaningfully represented in research is not only a scientific imperative—it is a moral one.
MENASA’s vision of a future where every patient, regardless of ethnicity, is represented in the science that shapes modern medicine and public health worldwide strongly resonates with my own commitment to inclusive, ethical, and globally relevant research. I’m eager to collaborate with colleagues across regions and disciplines to help translate this vision into measurable impact.
I’m excited for the work ahead and proud to stand alongside a community dedicated to transforming global health through representation, partnership, and innovation.”
Quoting Hadi Danawi’s post:
“Dr. Radwa Aly is a seasoned clinical research leader with more than 18 years of experience in clinical research administration and operations.
She currently serves in an executive leadership role at the George Washington University School of Medicine and Health Sciences, where she drives the strategic growth of high-impact translational clinical research and clinical trials across the academic medical enterprise.
She is deeply committed to advancing health equity and improving diversity in clinical trial recruitment, enrollment, and retention.
As co-founder and Director of the School of Medicine and Health Sciences Office of Clinical Research, she has helped increase the volume of supported clinical trials by 33% since 2021 and continues to champion team science, operational excellence, and mission-driven collaboration across academic medicine.”
